Related Experiment Videos

Timing and predictors of death in pediatric patients with multiple organ system failure

F Proulx1, M Gauthier, D Nadeau

  • 1Department of Pediatrics, Ste-Justine Hospital, Université de Montréal, PQ, Canada.

Insights

Pediatric patients with multiple organ system failure have a high mortality rate. Key risk factors for death include the number of organ failures, age under 12 months, and the PRISM score.

Area of Science:

  • Pediatric Intensive Care
  • Critical Care Medicine
  • Pediatric Critical Illness

Background:

  • Multiple organ system failure (MOSF) is a critical condition in pediatric intensive care units (ICUs).
  • Understanding the timing and risk factors for mortality in pediatric MOSF is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the onset of organ system failure, MOSF diagnosis, and death timing in pediatric ICU patients.
  • To identify independent risk markers for mortality in pediatric patients diagnosed with MOSF.

Main Methods:

  • A retrospective database review of 777 pediatric patients (<18 years) admitted to a tertiary care pediatric ICU.
  • Analysis of the timing of organ system failures, MOSF diagnosis, and death, along with multivariate analysis to identify risk factors.

Main Results:

  • MOSF occurred in 10.9% of patients, with 43.5% being postoperative cardiac surgery patients.
  • MOSF diagnosis and peak organ failures typically occurred early (within 72 hours of admission).
  • The overall mortality rate for pediatric MOSF was 50.6%, with most deaths occurring within 7 days of diagnosis. Independent risk factors for death included the maximum number of simultaneous organ failures, age ≤12 months, and the Pediatric Risk of Mortality (PRISM) score.

Conclusions:

  • Pediatric MOSF is associated with a high mortality rate.
  • Early identification of risk factors such as the number of organ failures, young age, and PRISM score is vital.
  • The early onset of MOSF and subsequent death suggests a need to re-evaluate the timing and efficacy of prophylactic therapies.
Abstract

Related Concept Videos